Showing results (781-790 of 3,472) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|September 18, 1998
Pharmacokinetic drug interactions with anti-ulcer drugsR D NegroClinical Pharmacokinetics|July 23, 1998
Clinical pharmacology of midazolam in infants and childrenJ L BlumerClinical Pharmacokinetics|September 1, 1979
Haemoperfusion in the management of digoxin toxicity: is it warranted?J T Slattery, J R KoupClinical Pharmacokinetics|March 1, 1979
A re-evaluation of intersubject variation in enzyme induction in manR A Branch, D G ShandClinical Pharmacokinetics|February 1, 1987
Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationshipsB N Swerdlow, F O HolleyClinical Pharmacokinetics|July 20, 2022
Quantitative Prediction of Drug Interactions Caused by Cytochrome P450 2B6 Inhibition or InductionVeronica Di Paolo, Francesco Maria Ferrari, Italo Poggesi, et al.Clinical Pharmacokinetics|May 4, 2023
Pharmacokinetics and Safety of Cotadutide, a GLP-1 and Glucagon Receptor Dual Agonist, in Individuals with Renal Impairment: A Single-Dose, Phase I, Bridging StudyGernot Klein, Marcella Petrone, Ye Yang, et al.Clinical Pharmacokinetics|August 21, 2020
Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With CancerNeeraj Gupta, Xiaohui Wang, Elliot Offman, et al.Clinical Pharmacokinetics|March 26, 2021
Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye DiseaseYan Xin, Fengyan Xu, Yuying Gao, et al.Clinical Pharmacokinetics|March 29, 2021
Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist TirzepatideShweta Urva, Tonya Quinlan, John Landry, et al.Pageof 348